Download - Supplementary Figure S7

Transcript
Page 1: Supplementary Figure S7

Supplementary Figure S7

Immunohistochemical confirmation of target inhibition by rapamycin (p-S6) and dasatinib (p-Src) in MMTV-PyMT tumor sections

CombinationVehicle Rapamycin Dasatinib

H&

Ep-

S6p-

Src

5 mm

Top Related

Supplementary Figure S26.

Supplementary Figure S26.

Supplementary Figure S1

Supplementary Figure S1

Supplementary figure 1

Supplementary figure 1

LEGENDS TO SUPPLEMENTARY FIGURES Supplementary Figure 1 ...

LEGENDS TO SUPPLEMENTARY FIGURES Supplementary Figure 1 ...

Supplementary Figures: Supplementary Figure 1 – PANCAN ...df6sxcketz7bb.cloudfront.net/manuscripts/88000/88755/jci.insight.88755.sd.pdfSupplementary Figures: Supplementary Figure

Supplementary Figures: Supplementary Figure 1 – PANCAN ...df6sxcketz7bb.cloudfront.net/manuscripts/88000/88755/jci.insight.88755.sd.pdfSupplementary Figures: Supplementary Figure

Supplementary figure 1

Supplementary figure 1

images.nature.com · Web viewSupplementary Figure 7 Supplementary Figure 3 Supplementary Figure 1 Supplementary Materials Supplementary Figures S1-S7 Supplementary Tables S1-S7 Clinical

images.nature.com · Web viewSupplementary Figure 7 Supplementary Figure 3 Supplementary Figure 1 Supplementary Materials Supplementary Figures S1-S7 Supplementary Tables S1-S7 Clinical

Final report on the supplementary comparison EURAMET.M.P-S7 · Final report on the supplementary comparison Euramet.M.P-S7 1/30 Final report on the supplementary comparison, Euramet.M.P-S7

Final report on the supplementary comparison EURAMET.M.P-S7 · Final report on the supplementary comparison Euramet.M.P-S7 1/30 Final report on the supplementary comparison, Euramet.M.P-S7

Languages
Pages
Legal

Copyright © 2022 FDOCUMENTS